Articles

  • 4 weeks ago | nytimes.com | Will Evans |Ellen Gabler |Anjali Tsui

    For more than a decade, Navindra Seeram, a biomedical researcher, has praised maple syrup, calling it a "hero ingredient" and "champion food" that could have wide-ranging health benefits. Dr. Seeram, dean of the School of Pharmacy at the University of New England, has published more than three dozen studies extolling the power of maple. Much of his work has been bankrolled by Canada's maple syrup industry and the Canadian and American governments.

  • 4 weeks ago | theexamination.org | Will Evans |Anjali Tsui |Ellen Gabler

    This article was reported in collaboration with The New York Times. For more than a decade, Navindra Seeram, a biomedical researcher, has praised maple syrup, calling it a “hero ingredient” and “champion food” that could have wide-ranging health benefits. Seeram, dean of the School of Pharmacy at the University of New England, has published more than three dozen studies extolling the power of maple.

  • Jan 17, 2025 | myheraldreview.com | Ellen Gabler

    Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.

  • Jan 15, 2025 | nytimes.com | Ellen Gabler

    Soon after being diagnosed with metastatic breast cancer, Virginia King sat in an outpatient clinic in Santa Fe, N.M, while a nurse injected her with a powerful drug to slow damage to her spine, where the disease had spread. Even though the drug had a list price of about $2,700, the hospital that owned the cancer center billed Mrs. King's insurance company $22,700. Her insurer paid $10,000, but the hospital wanted more.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
5K
Tweets
4K
DMs Open
Yes
Ellen Gabler
Ellen Gabler @egabler
15 Jan 25

I wrote about a controversial federal drug program that was created in the mid-1990s to help the poor. It has since ballooned - $66 billion in drug sales -- with the help of a private company called Apexus. Check it out. https://t.co/uJxfZQUkMc

Ellen Gabler
Ellen Gabler @egabler
13 Mar 23

Having problems getting your Xanax or Adderall? A major opioid settlement is affecting access to some common controlled substances, including those used to treat anxiety, pain, ADHD and addiction. @By_CJewett and I explain why. https://t.co/ba3fvsNW5D

Ellen Gabler
Ellen Gabler @egabler
8 Jul 22

ER doc @PEM_md on how she has grown accustomed to treating bullet-ridden children. "You are doing God's work," they say. Is it God’s work to hold mothers upright as their knees buckle? Is it God's work to see brain matter burst out of a child's skull? https://t.co/y8vC7MVBl0